Literature DB >> 27824818

Improving treatment of liver metastases by targeting nonangiogenic mechanisms.

Kyrre E Emblem1, Rakesh K Jain2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27824818     DOI： 10.1038/nm.4228

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases.

Authors:  Han-Sin Jeong; Dennis Jones; Shan Liao; Daniel A Wattson; Cheryl H Cui; Dan G Duda; Christopher G Willett; Rakesh K Jain; Timothy P Padera
Journal:  J Natl Cancer Inst       Date:  2015-06-10       Impact factor: 13.506

2.  Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases.

Authors:  Nuh N Rahbari; Dmitriy Kedrin; Joao Incio; Hao Liu; William W Ho; Hadi T Nia; Christina M Edrich; Keehoon Jung; Julien Daubriac; Ivy Chen; Takahiro Heishi; John D Martin; Yuhui Huang; Nir Maimon; Christoph Reissfelder; Jurgen Weitz; Yves Boucher; Jeffrey W Clark; Alan J Grodzinsky; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Sci Transl Med       Date:  2016-10-12       Impact factor: 17.956

3.  Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia.

Authors:  P B Vermeulen; C Colpaert; R Salgado; R Royers; H Hellemans; E Van Den Heuvel; G Goovaerts; L Y Dirix; E Van Marck
Journal:  J Pathol       Date:  2001-10       Impact factor: 7.996

Review 4.  Molecular mechanisms and clinical applications of angiogenesis.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

Review 5.  Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.

Authors:  Rakesh K Jain
Journal:  Cancer Cell       Date:  2014-11-10       Impact factor: 31.743

Review 6.  Modes of resistance to anti-angiogenic therapy.

Authors:  Gabriele Bergers; Douglas Hanahan
Journal:  Nat Rev Cancer       Date:  2008-08       Impact factor: 60.716

Review 7.  Hypoxia and the extracellular matrix: drivers of tumour metastasis.

Authors:  Daniele M Gilkes; Gregg L Semenza; Denis Wirtz
Journal:  Nat Rev Cancer       Date:  2014-05-15       Impact factor: 60.716

Review 8.  Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

Authors:  Tom Donnem; Jiangting Hu; Mary Ferguson; Omanma Adighibe; Cameron Snell; Adrian L Harris; Kevin C Gatter; Francesco Pezzella
Journal:  Cancer Med       Date:  2013-07-08       Impact factor: 4.452

9.  Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.

Authors:  Sophia Frentzas; Eve Simoneau; Victoria L Bridgeman; Peter B Vermeulen; Shane Foo; Eleftherios Kostaras; Mark Nathan; Andrew Wotherspoon; Zu-Hua Gao; Yu Shi; Gert Van den Eynden; Frances Daley; Clare Peckitt; Xianming Tan; Ayat Salman; Anthoula Lazaris; Patrycja Gazinska; Tracy J Berg; Zak Eltahir; Laila Ritsma; Jacco Van Rheenen; Alla Khashper; Gina Brown; Hanna Nystrom; Malin Sund; Steven Van Laere; Evelyne Loyer; Luc Dirix; David Cunningham; Peter Metrakos; Andrew R Reynolds
Journal:  Nat Med       Date:  2016-10-17       Impact factor: 53.440

10.  Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.

Authors:  F Stessels; G Van den Eynden; I Van der Auwera; R Salgado; E Van den Heuvel; A L Harris; D G Jackson; C G Colpaert; E A van Marck; L Y Dirix; P B Vermeulen
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640
  10 in total
  3 in total

Review 1.  Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges.

Authors:  John D Martin; Giorgio Seano; Rakesh K Jain
Journal:  Annu Rev Physiol       Date:  2019-02-10       Impact factor: 19.318

2.  A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.

Authors:  Amelie Griveau; Giorgio Seano; Samuel J Shelton; Robert Kupp; Arman Jahangiri; Kirsten Obernier; Shanmugarajan Krishnan; Olle R Lindberg; Tracy J Yuen; An-Chi Tien; Jennifer K Sabo; Nancy Wang; Ivy Chen; Jonas Kloepper; Louis Larrouquere; Mitrajit Ghosh; Itay Tirosh; Emmanuelle Huillard; Arturo Alvarez-Buylla; Michael C Oldham; Anders I Persson; William A Weiss; Tracy T Batchelor; Anat Stemmer-Rachamimov; Mario L Suvà; Joanna J Phillips; Manish K Aghi; Shwetal Mehta; Rakesh K Jain; David H Rowitch
Journal:  Cancer Cell       Date:  2018-04-19       Impact factor: 31.743

Review 3.  Critical considerations for targeting colorectal liver metastases with nanotechnology.

Authors:  Usman Arshad; Paul A Sutton; Marianne B Ashford; Kevin E Treacher; Neill J Liptrott; Steve P Rannard; Christopher E Goldring; Andrew Owen
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.